“This plan supports countries facing an acute mpox crisis or at high risk. It focuses on enhancing surveillance, lab capacity, community protection, clinical care, and vaccination efforts.
- Case Projections and Resource Needs:
- 1,000 weekly cases, potentially doubling in the first two months.
- Resources: 500 PCR tests, 5,000 RDTs, 20,000 vaccines weekly, treatment for 900 home cases, and 100 hospitalizations.
- Phase 1 of vaccination targets healthcare workers, requiring 2 million doses.
- Total cost: $135.8 million for coordination, technical support, and supplies.
- Monitoring and Evaluation:
- Indicators: surveillance coverage, case detection, vaccination rates, treatment outcomes, and community engagement.
- Data disaggregated by age, gender, and location to guide interventions.
- Real-time dashboards and regular progress reviews to adapt the response.
- Phased Vaccination Strategy:
- Phase 1: Vaccinate contacts of cases and healthcare workers in outbreak areas.
- Phase 2: Protect high-risk individuals.
- Phase 3: Increase population immunity in at-risk regions.
- Strategic Objectives:
- Strengthen surveillance and rapid response.
- Tailor interventions to community needs.
- Provide scalable, safe care with proper guidelines.
- Advance research and ensure equitable access to treatments.
- Collaborate across health sectors to prevent human-animal transmission.
Source:https://www.who.int/publications/m/item/mpox-global-strategic-preparedness-and-response-plan##~https://cdn.who.int/media/docs/default-source/documents/health-topics/monkeypox/draft_sprp_mpox_2024.pdf?sfvrsn=6d9df725_3&download=true
Region: All Markets
Meet Freya
August 2024
